Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 12 Week Randomized, Double-blind, Double-Dummy, Placebo-controlled Trial of Symbicort TM (160/4.5mcg) Versus Its Mono-Products (Budesonide and Formoterol) in Children (at Least 6years of Age) and Adults With Asthma-SPRUCE 80/4.5
Brief Summary: The purpose of this study is to compare Symbicort with its monocomponents budesonide and formoterol in the treatment of asthma in children and adults


Options:
A: Arm Label: Crossover sequence 1; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 100 mcg, Drug: Flovent Diskus® 250 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 2; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 100 mcg, Drug: Flovent Diskus® 250 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 3; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 100 mcg, Drug: Flovent Diskus® 250 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 4; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 100 mcg, Drug: Flovent Diskus® 250 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 5; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 250 mcg, Drug: Flovent Diskus® 500 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 6; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 250 mcg, Drug: Flovent Diskus® 500 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 7; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 250 mcg, Drug: Flovent Diskus® 500 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 8; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 250 mcg, Drug: Flovent Diskus® 500 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Intervention Type: DRUG; Name: Flovent Diskus® 100 mcg; Assigned to Arm(s): Crossover sequence 1, Crossover sequence 2, Crossover sequence 3, Crossover sequence 4 | Intervention Type: DRUG; Name: Flovent Diskus® 250 mcg; Assigned to Arm(s): Crossover sequence 1, Crossover sequence 2, Crossover sequence 3, Crossover sequence 4, Crossover sequence 5, Crossover sequence 6, Crossover sequence 7, Crossover sequence 8 | Intervention Type: DRUG; Name: Flovent Diskus® 500 mcg; Assigned to Arm(s): Crossover sequence 5, Crossover sequence 6, Crossover sequence 7, Crossover sequence 8 | Intervention Type: DRUG; Name: Advair Diskus® 100/50 mcg; Assigned to Arm(s): Crossover sequence 1, Crossover sequence 2, Crossover sequence 3, Crossover sequence 4, Crossover sequence 5, Crossover sequence 6, Crossover sequence 7, Crossover sequence 8 | Intervention Type: DRUG; Name: Advair Diskus® 250/50 mcg; Assigned to Arm(s): Crossover sequence 1, Crossover sequence 2, Crossover sequence 3, Crossover sequence 4, Crossover sequence 5, Crossover sequence 6, Crossover sequence 7, Crossover sequence 8
B: Arm Label: Fluticasone Furoate/Vilanterol; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone Furoate/Vilanterol Inhalation Powder, Other: Placebo Inhalation Powder 2 | Arm Label: Fluticasone Furoate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluticasone Furoate Inhalation Powder, Other: Placebo Inhalation Powder 2 | Arm Label: Fluticasone Propionate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluticasone Propionate Inhalation Powder, Other: Placebo Inhalation Powder 1 | Intervention Type: DRUG; Name: Fluticasone Furoate/Vilanterol Inhalation Powder; Assigned to Arm(s): Fluticasone Furoate/Vilanterol | Intervention Type: DRUG; Name: Fluticasone Furoate Inhalation Powder; Assigned to Arm(s): Fluticasone Furoate | Intervention Type: DRUG; Name: Fluticasone Propionate Inhalation Powder; Assigned to Arm(s): Fluticasone Propionate | Intervention Type: OTHER; Name: Placebo Inhalation Powder 1; Assigned to Arm(s): Fluticasone Propionate | Intervention Type: OTHER; Name: Placebo Inhalation Powder 2; Assigned to Arm(s): Fluticasone Furoate, Fluticasone Furoate/Vilanterol
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Symbicort pMDI | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: budesonide pMDI | Intervention Type: DRUG; Name: Symbicort pMDI; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: budesonide pMDI; Assigned to Arm(s): 2
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: budesonide/formoterol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: budesonide | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: formoterol | Intervention Type: DRUG; Name: budesonide/formoterol; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: budesonide; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: formoterol; Assigned to Arm(s): 3

Answer: D